14 documents found, page 1 of 2

Sort by Issue Date

Securing wider EU commitment to the elimination of hepatitis C virus

Wedemeyer, Heiner; Tergast, Tammo L.; Lazarus, Jeffrey V.; Razavi, Homie; Bakoyannis, Kostas; Baptista-Leite, Ricardo; Bartoli, Marco; Bruggmann, Philip

In 2016, the Hepatitis B and C Public Policy Association (HepBCPPA), gathered all the main stakeholders in the field of hepatitis C virus (HCV) to launch the now landmark HCV Elimination Manifesto, calling for the elimination of HCV in the EU by 2030. Since then, many European countries have made progress towards HCV elimination. Multiple programmes—from the municipality level to the EU level—were launched, res...


Let's End HepC: modelling public health epidemiological policies applied to Hep...

Lopes, Henrique; Baptista-Leite, Ricardo; Franco, Diogo; Serra, Miguel A.; Escudero, Amparo; Martín-Moreno, José M.

Background: The WHO has defined international targets toward the elimination of hepatitis C by 2030. Most countries cannot be on track to achieve this goal unless many challenges are surpassed. The Let's End HepC (LEHC) tool aims to contribute to the control of hepatitis C. The innovation of this tool combines the modelling of public health policies (PHP) focused on hepatitis C with epidemiological modelling of...


A multinational Delphi consensus to end the COVID-19 public health threat

COVID-19 Consensus Statement Panel; Lazarus, Jeffrey V.; Romero, Diana; Kopka, Christopher J.; Karim, Salim Abdool; Abu-Raddad, Laith J.

Despite notable scientific and medical advances, broader political, socioeconomic and behavioural factors continue to undercut the response to the COVID-19 pandemic1,2. Here we convened, as part of this Delphi study, a diverse, multidisciplinary panel of 386 academic, health, non-governmental organization, government and other experts in COVID-19 response from 112 countries and territories to recommend specific...


Integrating public health policies in the epidemiological modeling of hepatitis...

Lopes, Henrique; Baptista-Leite, Ricardo; Franco, Diogo; Pirke, Roxana; Gschwantler, Michael

Background: Eliminating hepatitis C requires addressing issues other than medicines or therapies. Public health policies focused on the hepatitis C virus (HCV) must be emphasized and worked to know the impacts on its epidemiologic dynamics. This research aims to provide a tool to evaluate and simulate alternatives by redefining policies meeting specific needs in each country towards the HCV elimination target b...


Fighting Hepatitis C in a COVID-19 ecosystem. Public health policies are needed...

Lopes, Henrique; Baptista-Leite, Ricardo; Franco, Diogo; Kundurzhiev, Todor; Mateva, Lyudmila; Jelev, Dejan; Simonova, Marieta


Modeling the puzzle of hepatitis C epidemiology in Romania: a pathway to control

Lopes, Henrique; Baptista-Leite, Ricardo; Franco, Diogo; Eclemea, Irina; Bratu, Eugenia C.; Furtunescu, Florentina L.; Pop, Corina Silvia

Background & Aims: To combat hepatitis C virus (HCV) and achieve its elimination by 2030, the emphasis should be on public health policies. In this study, we investigated the dynamics of epidemiology of HCV in Romanian risk groups that are characterized by higher occurrence densities with the aid of The Let’s End HepC (LEHC) project. Methods: The LEHC project addressed the modelling of HCV epidemiology, being a...


Biologicals and Biosimilars: Gaps in the Pharmacovigilance System in Portugal

Portela, Maria da Conceição Constantino; Sinogas, Carlos; Almeida, Fernando Albuquerque; Baptista-Leite, Ricardo; Castro-Caldas, Alexandre

Introdução: A monitorização da segurança associada aos medicamentos biológicos e biossimilares exige um sistema de informação alinhado com o enquadramento regulamentar. Tendo em conta que podem ocorrer descontinuidades entre a regulamentação europeia, nacional e a respetiva tradução operacional, importa pesquisar e identificar essas lacunas. Material e Métodos: Foi desenvolvida uma análise qualitativa dos supor...


Biologicals and biosimilars: safety issues in Europe

Portela, Maria da Conceição; Sinogas, Carlos; Almeida, Fernando; Baptista-Leite, Ricardo; Castro-Caldas, Alexandre

ABSTRACT Introduction: Medicinal products of a biological origin are approved by the EMA at a centralized level. However, there is no harmonization about their use in Europe. The current regulation referring to the safety of biological medicinal products and biosimilars in Europe has been identified. The safety associated with medicinal products of a biological origin is assured by the pharmacovigilance system,...


Innovative strategies for the elimination of viral hepatitis at a national leve...

Schröeder, Sophia E.; Pedrana, Alisa; Scott, Nick; Wilson, David; Kuschel, Christian; Aufegger, Lisa; Atun, Rifat; Baptista-Leite, Ricardo

Viral hepatitis is a leading cause of morbidity and mortality worldwide, but has long been neglected by national and international policymakers. Recent modelling studies suggest that investing in the global elimination of viral hepatitis is feasible and cost-effective. In 2016, all 194 member states of the World Health Organization endorsed the goal to eliminate viral hepatitis as a public health threat by 2030...


The road towards the responsible and safe legalization of cannabis use in Portugal

Baptista-Leite, Ricardo; Ploeg, Lisa

Introduction: Recently, the world has seen examples of the legalization of cannabis for recreational purposes. Due to the diversity of experiences in progress, it is urgent to analyze the impacts of this legalization, from a public health perspective. Therefore, this article aims to review the accumulated knowledge in the states and countries where the use of cannabis is legal and to ponder over the relevance o...


14 Results

Queried text

Refine Results

Author





















Date









Document Type


Access rights


Resource




Subject